MD up +0.42% percent Today $MD High is at 62.84 and the Low

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
MD up +0.42% percent Today $MD High is at 62.84 and the Low 62.24 with current volume of 108,645.

Recent News posted below.

Mednax Inc MD other info.
http://investorshangout.com/Mednax-Inc-MD-51757/

MD Mednax Inc Recent Headline News

Shares of MD Up 13.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 12, 9:28AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 3 weeks, Mednax has returned 13.83% as of today's recent price of $61.89.
MD: 62.80 (+0.47)

MEDNAX to Present at the Stifel 2014 Healthcare Conference
Business Wire - Wed Nov 12, 6:00AM CST
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Tuesday, November 18, 2014 at 11:30 a.m. EST to investors attending the Stifel 2014 Healthcare Conference in New York.
MD: 62.80 (+0.47)

Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Mednax Is Up 1.1% (MD)
Comtex SmarTrend(R) - Mon Nov 10, 1:47PM CST
When Mednax (NYSE:MD) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.85 on sales of $619.3 million. Mednax actually reported earnings of $0.86 per share on sales of $626.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $7.2 million. Since the company's report, shares of Mednax have risen from $61.50 to $62.18, representing a gain of 1.1% in the past 11 days.
MD: 62.80 (+0.47)

MEDNAX to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire - Fri Nov 07, 6:00AM CST
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Tuesday, November 11, 2014 at 4:30 p.m. MST to investors attending the 2014 Credit Suisse Healthcare Conference in Phoenix.
MD: 62.80 (+0.47)

Mednax: Improving Bargaining Position, But Some Risks Ahead
Investing Doc - Seeking Alpha - Wed Nov 05, 10:38AM CST
My previous investment thesis for Mednax (NYSE: MD ) remains intact after reviewing the company's third quarter results, and while shares are less attractive than they had been after last week's jump in price, I still view them as undervalued after...
MD: 62.80 (+0.47)

Mednax Shares Up 15.4% Since SmarTrend's Buy Recommendation (MD)
Comtex SmarTrend(R) - Wed Nov 05, 9:33AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 2 weeks, Mednax has returned 15.42% as of today's recent price of $62.76.
MD: 62.80 (+0.47)

MEDNAX's (MD) CEO Roger Medel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 1:30PM CDT

MD: 62.80 (+0.47)

NYSE stocks posting largest percentage increases
AP - Thu Oct 30, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
CALX: 10.99 (+0.26), NFX: 33.64 (+0.74), EGL: 44.10 (+0.57), V: 249.13 (-1.79), MPLX: 68.27 (+1.07), GNC: 43.36 (-0.30), VHI: 5.80 (+0.15), ROG: 72.16 (+0.18), ACCO: 9.00 (+0.20), CEB: 74.19 (-0.18), FLTX: 37.19 (+0.21), MD: 62.80 (+0.47)

Mednax (MD) Marked As A Barbarian At The Gate
at The Street - Thu Oct 30, 9:46AM CDT
Trade-Ideas LLC identified Mednax (MD) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MD: 62.80 (+0.47)

Mednax (MD) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:55AM CDT

MD: 62.80 (+0.47)

Mednax beats Street 3Q forecasts
Automated Insights - Thu Oct 30, 5:54AM CDT
SUNRISE, Fla. (AP) _ Mednax Inc. (MD) on Thursday reported earnings of $86.2 million in its third quarter.
MD: 62.80 (+0.47)

Mednax beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:18AM CDT

MD: 62.80 (+0.47)

MEDNAX Reports 2014 Third Quarter EPS of $0.86
Business Wire - Thu Oct 30, 5:01AM CDT
--Credit Facility Expanded to $1.5 Billion
MD: 62.80 (+0.47)

Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 70.11 (+0.91), ESRX: 78.03 (+0.13), DVA: 75.84 (-1.20), DGX: 62.57 (-1.20), MD: 62.80 (+0.47)

MEDNAX Announces Acquisition of Anesthesiology Practice in Georgia
Business Wire - Wed Oct 29, 6:00AM CDT
MEDNAX, Inc. (NYSE: MD) today announced the signing of a definitive agreement to acquire The NEXus Medical Group, LLC and its subsidiary, Meridian Anesthesia Consultants, LLC in Macon, Georgia.
MD: 62.80 (+0.47)

MedData Launches iPhone App to Improve Billing Reconciliation for Surgical Practices
Business Wire - Thu Oct 23, 8:02AM CDT
MedData, Inc., a leading national provider of "patient-focused" revenue cycle management and patient financial lifecycle services, announced the launch of Patient Lists, a new iPhone app designed to streamline the medical billing process for its surgical clients.
MD: 62.80 (+0.47)

Edgemont Capital Partners Completes Sale of Premier Physician Services to TeamHealth
Business Wire - Wed Oct 22, 5:01PM CDT
Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to Premier Physician Services, Inc. ("Premier" in the sale of the company to TeamHealth Holdings Inc. (NYSE:TMH). Terms of the transaction were not disclosed.
EVHC: 32.70 (+0.25), TMH: 54.39 (+0.48), MD: 62.80 (+0.47)

MEDNAX Announces Acquisition of Perinatology Practice in Texas
Business Wire - Mon Oct 20, 6:00AM CDT
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Houston Perinatal Associates, P.A., a private physician group practice based in Houston, Texas. The practice will become part of MEDNAX's Pediatrix Medical Group division.
MD: 62.80 (+0.47)

HCA Holdings Gives Peek into Q4 Earnings, 2014 Guide Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 3:15PM CDT
HCA Holdings, Inc. (HCA) announced its preliminary financial and operating results for the third quarter of 2014.
ACHC: 61.53 (+0.24), HCA: 63.12 (-1.65), THC: 46.97 (-0.97), MD: 62.80 (+0.47)

MEDNAX 2014 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 30, 2014
Business Wire - Thu Oct 09, 6:00AM CDT
MEDNAX, Inc. (NYSE:MD), will host an investor conference call and webcast on Thursday, October 30, 2014 at 10:00 a.m. EDT, to discuss results from operations for the quarter and the nine months ended September 30, 2014. A detailed press release will be issued the morning of October 30, 2014 before the securities markets open.
MD: 62.80 (+0.47)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 2

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Chattanooga: A New Epicenter for Quantum Computing

Updated Category News Views 4

Quantum Leap: Chattanooga's Bold Move So Chattanooga’s making waves again, folks. EPB just unveiled its new big shot, the IonQ Forte Enterprise quantum computer. That's right, they’ve slapped a commercial quantum computer and a networking hub together, right here in this Tennessee city. Is this a tech haven or what? Not to mention, it’s the first in America. A New...

Continue Reading
Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 2

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
Fly High: Encouraging Girls to Soar into Aviation

Updated Category News Views 4

The Sky's Not the Limit—It's Just the Beginning Step aside, conventional paths. There's a flight school owner in Sedona, Arizona, making waves by encouraging girls to swap their land-bound dreams for sky-high aspirations. This International Girls in Aviation Day, Michelle Smith wants young dreamers to know their possibilities span as wide as the open sky. Defying...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 2

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
2026 Lantern Festival Shines in Kunshan Amid Tensions

Updated Category News Views 4

Lanterns Illuminate Cross-Strait Relations Under the shadow of geopolitical tensions, the 2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival kicked off with a splash on September 16. Held in Kunshan, Suzhou, this cultural festival offers a rare glimpse of cooperation and shared cultural celebration across the Taiwan Strait. Through lantern displays, art exhibitions,...

Continue Reading
Mental Health Day Celebrations Set for October in NYC

Updated Category News Views 7

Mental Health Steals the October Spotlight In the bustling streets of New York City, October is about to get a mental health makeover. Project Healthy Minds is putting the pedal to the metal with their fourth annual World Mental Health Day Gala on October 8th, followed by the world’s largest mental health festival on October 10th. These events, held at Spring Studios,...

Continue Reading
Ensuring Your Radon Mitigation System Stays Effective

Updated Category News Views 3

Radon Mitigation: A Critical Measure for Home Safety Homeowners, you're probably aware of the ticking health time bomb known as radon. Not just an annoying gas, this colorless, odorless beast lurks quietly, threatening family health if not managed right. Mitch Kelley, a specialist in radon testing with Basement Solutions in Mankato, Minnesota, lays out a no-fuss guide to...

Continue Reading
Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 1

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 7

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading

Top 5 Most Recently Viewed Articles

Mark Cuban's Timeless Wisdom on Managing Credit Card Debt

Updated Category News Views 267

Credit card debt became a mounting problem for many consumers, hitting a staggering $1.14 trillion recently. This hefty figure marked an alarming increase of $27 billion in just one quarter—definitely not the kind of trend any trader or financial guru wants to see. Traders were buzzing about this spike back then, grappling with what it meant for consumer spending and...

Continue Reading
Tachyus Partners with Anschutz for Enhanced Carbon Management

Updated Category News Views 164

Tachyus Partners with Anschutz Exploration Tachyus has announced an exciting collaboration with Anschutz Exploration to implement Aurion, its innovative platform designed for efficient greenhouse gas (GHG) emissions management. This contract marks a significant step for Anschutz, aiming to establish a comprehensive GHG baseline while effectively monitoring and forecasting...

Continue Reading
Sampo plc Enhances Share Buyback Program: Key Updates

Updated Category News Views 110

Sampo plc's Share Buyback Program: An Overview Sampo plc has made significant strides in its share buyback initiatives. As shareholders, it is essential to stay updated on how these developments may affect your investments. Recently, the company disclosed its activities regarding A share repurchases, which offer insights into its strategic approach in the market. Details...

Continue Reading
Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH

Updated Category News Views 373

Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...

Continue Reading
Innovative Breakthrough in Cancer Treatment with NX-5948

Updated Category News Views 287

Exciting Clinical Results for NX-5948 In a noteworthy development, Nurix Therapeutics, Inc. has shared promising results from their ongoing Phase 1a/1b clinical trial of NX-5948, aimed at treating patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM). In this trial, NX-5948, a targeted degrader of Burton's tyrosine kinase (BTK), demonstrated...

Continue Reading